Indian Leaders Climb Into Generics And Biosimilars Top 10
Companies Lower Down In The Top 50 See Movement Amid Mixed Fortunes
In a year that has seen significant changes throughout the generics and biosimilars industry ranking, the top 10 has welcomed two Indian off-patent leaders. Meanwhile, companies lower down our ranking have enjoyed mixed fortunes, leading to a number of significant movements in this year’s Generics Bulletin Top 50.
